Publications by authors named "Teiko Sumiyoshi"

Claim this Profile
P
Phase I Study of Safety and Pharmacokinetics of RO7297089, an Anti-BCMA/CD16a Bispecific Antibody, in Patients with Relapsed, Refractory Multiple Myeloma.
Torben Plesner, Simon J Harrison, Hang Quach, Cindy Lee, Adam Bryant, Teiko Sumiyoshi

Clin Hematol Int· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A BCMA/CD16A bispecific innate cell engager for the treatment of multiple myeloma.
Satoko Kakiuchi-Kiyota, Thorsten Ross, Heidi Ackerly Wallweber, James R Kiefer, Melissa M Schutten, Teiko Sumiyoshi

Leukemia· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bimodal expression of potential drug target CLL-1 (CLEC12A) on CD34+ blasts of AML patients.
Lok Lam Ngai, Connie Y Ma, Orla Maguire, An D Do, Alberto Robert, Teiko Sumiyoshi

Eur J Haematol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase I dose-escalation study of DCLL9718S, an antibody-drug conjugate targeting C-type lectin-like molecule-1 (CLL-1) in patients with acute myeloid leukemia.
Naval Daver, Amandeep Salhotra, Joseph M Brandwein, Nikolai A Podoltsev, Daniel A Pollyea, Teiko Sumiyoshi

Am J Hematol· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence Study of PD-L1 SP142 Assay in Metastatic Triple-negative Breast Cancer.
Yijin Li, Bharathi Vennapusa, Ching-Wei Chang, David Tran, Rin Nakamura, Teiko Sumiyoshi

Appl Immunohistochem Mol Morphol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Absence of PD-L1 expression on tumor cells in the context of an activated immune infiltrate may indicate impaired IFNγ signaling in non-small cell lung cancer.
Willemijn S M E Theelen, Thomas Kuilman, Katja Schulze, Wei Zou, Oscar Krijgsman, Teiko Sumiyoshi

PLoS One· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Clinically Applicable Gene-Expression Classifier Reveals Intrinsic and Extrinsic Contributions to Consensus Molecular Subtypes in Primary and Metastatic Colon Cancer.
Robert Piskol, Ling Huw, Ismail Sergin, Christiaan Kljin, Zora Modrusan, Teiko Sumiyoshi

Clin Cancer Res· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A transcriptional MAPK Pathway Activity Score (MPAS) is a clinically relevant biomarker in multiple cancer types.
Marie-Claire Wagle, Daniel Kirouac, Christiaan Klijn, Bonnie Liu, Shilpi Mahajan, Teiko Sumiyoshi

NPJ Precis Oncol· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Membrane-Proximal Epitope Facilitates Efficient T Cell Synapse Formation by Anti-FcRH5/CD3 and Is a Requirement for Myeloma Cell Killing.
Ji Li, Nicola J Stagg, Jennifer Johnston, Michael J Harris, Sam A Menzies, Teiko Sumiyoshi

Cancer Cell· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The molecular landscape of high-risk early breast cancer: comprehensive biomarker analysis of a phase III adjuvant population.
Timothy R Wilson, Jianjun Yu, Xuyang Lu, Jill M Spoerke, Yuanyuan Xiao, Teiko Sumiyoshi

NPJ Breast Cancer· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Next generation MUT-MAP, a high-sensitivity high-throughput microfluidics chip-based mutation analysis panel.
Erica B Schleifman, Rachel Tam, Rajesh Patel, Alison Tsan, Teiko Sumiyoshi

PLoS One· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a robust RNA-based classifier to accurately determine ER, PR, and HER2 status in breast cancer clinical samples.
Timothy R Wilson, Yuanyuan Xiao, Jill M Spoerke, Jane Fridlyand, Hartmut Koeppen, Teiko Sumiyoshi

Breast Cancer Res Treat· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted biomarker profiling of matched primary and metastatic estrogen receptor positive breast cancers.
Erica B Schleifman, Rupal Desai, Jill M Spoerke, Yuanyuan Xiao, Cheryl Wong, Teiko Sumiyoshi

PLoS One· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Profiling cancer gene mutations in clinical formalin-fixed, paraffin-embedded colorectal tumor specimens using targeted next-generation sequencing.
Liangxuan Zhang, Liangjing Chen, Sachin Sah, Gary J Latham, Rajesh Patel, Teiko Sumiyoshi

Oncologist· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nonmyeloablative conditioning regimen to increase engraftment of gene-modified hematopoietic stem cells in young rhesus monkeys.
Alice F Tarantal, Francesca Giannoni, C Chang I Lee, Jennifer Wherley, Teiko Sumiyoshi

Mol Ther· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stable transgene expression in primitive human CD34+ hematopoietic stem/progenitor cells, using the Sleeping Beauty transposon system.
Teiko Sumiyoshi, Nathalia G Holt, Roger P Hollis, Shundi Ge, Paula M Cannon

Hum Gene Ther· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lentiviral vector transduction of a dominant-negative Rev gene into human CD34+ hematopoietic progenitor cells potently inhibits human immunodeficiency virus-1 replication.
Ingrid Bahner, Teiko Sumiyoshi, Mercy Kagoda, Robin Swartout, Denise Peterson

Mol Ther· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CpeR is an activator required for expression of the phycoerythrin operon (cpeBA) in the cyanobacterium Fremyella diplosiphon and is encoded in the phycoerythrin linker-polypeptide operon (cpeCDESTR).
John G Cobley, A Clay Clark, Siromi Weerasurya, F Anne Queseda, Jimmy Y Xiao, Teiko Sumiyoshi

Mol Microbiol· June 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis